Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
Pfizer enters into an exclusive licensing agreement with 3SBio
Under the terms of the agreement, 3SBio will grant Pfizer an exclusive global license to develop, manufacture and commercialise…
Department of Biotechnology, BIRAC host webinar on Biomanufacturing for mRNA Therapeutics
The 14th webinar of the biomanufacturing and biofoundry initiative served as a collaborative forum, bringing together academia,…
Venus Remedies joins United Nations Global Compact
As a UNGC participant, the company will publish an annual CoP to share updates on its sustainability performance and adherence to…
US drug pricing order – Implications for India’s pharma sector
Ravi Shah, Partner, Cyril Amarchand Mangaldas explains that while the policy is designed to cut costs for US patients, its effects…
GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients:…
In both groups, Nucala significantly lowered the rate of exacerbations requiring emergency department (ED) visits or…
ICON retains lead as most active CRO in Q1 2025, reveals GlobalData
GlobalData’s Q1 2025 report highlights ICON’s continued CRO dominance, Russia’s clinical trial volume lead in Europe, and…
Punita Lal joins Lupin board as Additional Director
Former Coca-Cola and PepsiCo executive joins Lupin’s Board of Directors as Non-Executive Independent Director
Panel Discussion: Leadership playbook for scaling pharma businesses
Ahmedabad Pharma Summit 2025 | 16th April 2025
Mr Vipul Doshi, Chief Quality and Compliance Officer, Zydus Life Sciences
Ahmedabad Pharma Summit 2025 | 16th April 2025